PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Infectious Diseases, Hospital Clinic, Barcelona, Spain.\', \'Unit of Infectious Diseases, Internal Medicine Department, La Paz University Hospital, Madrid, Spain.\', \'Unit of Infectious Diseases, Internal Medicine Department, Principe de Asturias University Hospital, Madrid, Spain.\', \'Intensive Care Department, La Paz University Hospital, Madrid, Spain.\', \'Pharmacy Department, Hospital del Mar, Barcelona, Spain.\', \'Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.\', \'Gilead Sciences, Madrid, Spain.\', \'Pharmacoeconomics and Market Access Department, Weber, Madrid, Spain.\', \'Economy and Health Research Seminar, University of Castilla-La Mancha, Toledo, Spain.\', \'Foundation Weber, Madrid, Spain.\', \'Pharmacoeconomics and Market Access Department, Weber, Madrid, Spain. almudena.gonzalez@weber.org.es.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-021-01804-9
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 34118007
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34118007>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34118007>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all